Literature DB >> 28799985

Rapid detection of bacterial meningitis using a point-of-care glucometer.

Geoffroy Rousseau1,2, Romain Asmolov3,2, Leslie Grammatico-Guillon4,2, Adrien Auvet3,2, Said Laribi1,2, Denis Garot5, Youenn Jouan5,2, Pierre-François Dequin5,2, Antoine Guillon5,2.   

Abstract

BACKGROUND: In case of acute bacterial meningitis, a decision on the need for intensive care admission should be made within the first hour. The aim of this study was to assess the ability of a point-of-care glucometer to determine abnormal cerebrospinal fluid (CSF) glucose concentration at the bedside that contributes toward bacterial meningitis diagnosis.
METHODS: We carried out a prospective study and simultaneously measured the glucose concentrations in CSF and blood using a central laboratory and a point-of-care glucometer. We compared CSF/blood glucose ratios obtained at the bedside with a glucometer versus those obtained by the central laboratory. We determined the performance characteristics of the CSF/blood glucose ratio provided by a glucometer to detect bacterial infection in the CSF immediately after CSF sampling.
RESULTS: We screened 201 CSF collection procedures during the study period and included 172 samples for analysis. Acute bacterial meningitis was diagnosed in 17/172 (9.9%) of CSF samples. The median turnaround time for a point-of-care glucometer analysis was 5 (interquartile range 2-10) min versus 112 (interquartile range 86-154) min for the central laboratory (P<0.0001). The optimal cut-off of the CSF/blood glucose ratio calculated from a bedside glucometer was 0.46, with a sensitivity of 94.1% (95% confidence interval: 71.3-99.9%), a specificity of 91% (95% confidence interval: 85.3-95%), and a positive likelihood ratio of 10.
CONCLUSION: A glucometer accurately detects an abnormal CSF/blood glucose ratio immediately after the lumbar puncture. This cheap point-of-care method has the potential to speed up the diagnostic process of patients with bacterial meningitis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 28799985     DOI: 10.1097/MEJ.0000000000000495

Source DB:  PubMed          Journal:  Eur J Emerg Med        ISSN: 0969-9546            Impact factor:   2.799


  5 in total

1.  Shorten the door-to-antibiotics time in acute bacterial meningitis using a glucometer to measure the cerebrospinal fluid/blood glucose ratio.

Authors:  Geoffroy Rousseau; Lola Gonzalez; Antoine Guillon; Leslie Grammatico-Guillon; Said Laribi
Journal:  Intern Emerg Med       Date:  2021-07-22       Impact factor: 3.397

Review 2.  Small-volume detection: platform developments for clinically-relevant applications.

Authors:  Wei-Hsuan Sung; Yu-Ting Tsao; Ching-Ju Shen; Chia-Ying Tsai; Chao-Min Cheng
Journal:  J Nanobiotechnology       Date:  2021-04-21       Impact factor: 10.435

3.  Predicting the microbial cause of community-acquired pneumonia: can physicians or a data-driven method differentiate viral from bacterial pneumonia at patient presentation?

Authors:  Claire Lhommet; Denis Garot; Leslie Grammatico-Guillon; Cassandra Jourdannaud; Pierre Asfar; Christophe Faisy; Grégoire Muller; Kimberly A Barker; Emmanuelle Mercier; Sylvie Robert; Philippe Lanotte; Alain Goudeau; Helene Blasco; Antoine Guillon
Journal:  BMC Pulm Med       Date:  2020-03-06       Impact factor: 3.317

4.  Sensitivity and specificity of cerebrospinal fluid glucose measurement by an amperometric glucometer.

Authors:  Ahmed S Alkhalifah; Khalid A Alqatari; Abdullah A Alkhalifa; Baneen A Akakah; Zainab S Alobaid
Journal:  Saudi Med J       Date:  2020-06       Impact factor: 1.484

5.  Comment on: Sensitivity and specificity of cerebrospinal fluid glucose measurement by an amperometric glucometer.

Authors:  Sarar Mohamed
Journal:  Saudi Med J       Date:  2020-08       Impact factor: 1.484

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.